These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 4445956)

  • 21. Midtrimester abortion by prostaglandin impact.
    Saldana LR; Schulman H; Yang WH; Cunningham MA; Randolph G
    Obstet Gynecol; 1974 Oct; 44(4):579-85. PubMed ID: 4414679
    [No Abstract]   [Full Text] [Related]  

  • 22. The intra-amniotic administration of prostaglandin f-2-alpha with intravenous oxytocin for the induction of midtrimester abortion.
    Laitinen S; Pystynen P
    Ann Chir Gynaecol Fenn; 1974; 63(1):35-8. PubMed ID: 4832154
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparison of intra-amniotic (15S)-15-methyl-PGF2 alpha and intravaginal prostaglandin E2 for second-trimester uterine evacuation.
    Perry KG; Roberts WE; Martin RW; Magann EF; Sullivan DL; Morrison JC
    J Perinatol; 1998; 18(1):24-7. PubMed ID: 9527940
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Termination of second trimester pregnancy with single intra-amniotic and extra-amniotic instillation of prostaglandin F2 alpha and 15-methyl prostaglandin F2 alpha.
    Sethi A; Jalnawalla SF
    J Obstet Gynaecol India; 1979 Apr; 29(2):274-82. PubMed ID: 12335893
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intra-amniotic administration of prostaglandin F 2 for abortion.
    Wentz AC; Cushner IM; Austin K; Shams M
    Am J Obstet Gynecol; 1972 Jul; 113(6):793-803. PubMed ID: 4635715
    [No Abstract]   [Full Text] [Related]  

  • 26. Pregnancy termination in midtrimester --reviews of major methods--.
    Chaudry SL; Hunt WB; Wortman J
    Popul Rep F; 1976 Sep; (5):65-83. PubMed ID: 791731
    [No Abstract]   [Full Text] [Related]  

  • 27. [Use of PGF2 alpha to induce abortion in patients with risk factors in first and second thirds of gravidity (author's transl)].
    Rudolf K; Frahm R
    Zentralbl Gynakol; 1980; 102(10):575-83. PubMed ID: 7467928
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of prostaglandins and their analogues for abortion.
    Bygdeman M
    Clin Obstet Gynaecol; 1984 Dec; 11(3):573-84. PubMed ID: 6391777
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic abortion in the second trimester by intra-amniotic prostaglandin F 2 .
    Ballard CA; Quilligan EJ
    J Reprod Med; 1972 Dec; 9(6):397-9. PubMed ID: 4648918
    [No Abstract]   [Full Text] [Related]  

  • 30. Uterine rupture complicating midtrimester abortion. A report of two cases.
    Hagay ZJ; Leiberman JR; Picard R; Katz M
    J Reprod Med; 1989 Nov; 34(11):912-6. PubMed ID: 2685289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison between intra-amniotic administration of prostaglandin F2alpha and its 15-methyl derivative for induction of second trimester abortion.
    Ylikorkala O; Järvinen PA
    Ann Clin Res; 1977 Apr; 9(2):58-61. PubMed ID: 329742
    [No Abstract]   [Full Text] [Related]  

  • 32. Therapeutic abortion in the second trimester by intra-amniotic prostaglandin F2 alpha .
    Gillett PG; Kinch RA; Wolfe LS; Pace-Asciak C
    J Reprod Med; 1972 Dec; 9(6):416-9. PubMed ID: 4648921
    [No Abstract]   [Full Text] [Related]  

  • 33. Introduction of second trimester abortions with 15-(S)-methyl prostaglandin F2alpha by intra-uterine and intramuscular routes.
    Hingorani V; Agarwal N; Bhadury R; Singh CM; Baliga N; Tekumalla L
    J Indian Med Assoc; 1976 Jun; 66(11):279-83. PubMed ID: 977973
    [No Abstract]   [Full Text] [Related]  

  • 34. Interruption of pregnancy by PGF2 alpha. I. Intraamniotic administration.
    Szontágh FE; Szabó E; Tekulics A; Kovács I
    Acta Eur Fertil; 1972 Dec; 3(4):363-72. PubMed ID: 4679685
    [No Abstract]   [Full Text] [Related]  

  • 35. Termination of mid-term spontaneous and missed abortions by extra-amniotic injection of a single prostaglandin F2alpha dose.
    Kerekes L; Domokos N
    Ther Hung; 1977; 25(3):102-4. PubMed ID: 929474
    [No Abstract]   [Full Text] [Related]  

  • 36. Induction of abortion with prostaglandins: clinical and metabolic aspects.
    Bygdeman M; Wiqvist N
    S Afr Med J; 1974 Oct; 0(0):Suppl:3-8. PubMed ID: 4418571
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinical experiences with prostaglandin E 2 and F 2 alpha in the termination of pregnancy and labor induction in intrauterine fetal death].
    Kunz J; Schreiner WE
    Schweiz Med Wochenschr; 1977 Jun; 107(22):757-63. PubMed ID: 877524
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A generalized epileptiform convulsion after intra-amniotic prostaglandin with intravenous oxytocin infusion: a case report.
    Kaplan E
    S Afr Med J; 1978 Jan; 53(1):27-9. PubMed ID: 644406
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Induction of abortion during the second and third trimester of pregnancy with sulprostone (author's transl)].
    Heinzl S; Winkler C
    Geburtshilfe Frauenheilkd; 1981 Mar; 41(3):231-6. PubMed ID: 7215768
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Therapeutic abortions in the second trimestre of pregnancy with prostaglandine gel (author's transl)].
    Heinzl S
    Geburtshilfe Frauenheilkd; 1978 Mar; 38(3):220-6. PubMed ID: 640366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.